Outdoor Adventure Mats
The research report includes specific segments by region (country), by company, by Type and by Sa ... Read More
Global Liver Diseases Therapeutics Drugs Market Research Report 2023
1 Liver Diseases Therapeutics Drugs Market Overview
1.1 Product Overview and Scope of Liver Diseases Therapeutics Drugs
1.2 Liver Diseases Therapeutics Drugs Segment by Type
1.2.1 Global Liver Diseases Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028)
1.2.2 Oral Liver Diseases Therapeutics Drugs
1.2.3 Injection Liver Diseases Therapeutics Drugs
1.3 Liver Diseases Therapeutics Drugs Segment by Application
1.3.1 Global Liver Diseases Therapeutics Drugs Sales Comparison by Application: (2022-2028)
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Global Liver Diseases Therapeutics Drugs Market Size Estimates and Forecasts
1.4.1 Global Liver Diseases Therapeutics Drugs Revenue 2017-2028
1.4.2 Global Liver Diseases Therapeutics Drugs Sales 2017-2028
1.4.3 Liver Diseases Therapeutics Drugs Market Size by Region: 2017 Versus 2021 Versus 2028
2 Liver Diseases Therapeutics Drugs Market Competition by Manufacturers
2.1 Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
2.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Manufacturers (2017-2022)
2.3 Global Liver Diseases Therapeutics Drugs Average Price by Manufacturers (2017-2022)
2.4 Manufacturers Liver Diseases Therapeutics Drugs Manufacturing Sites, Area Served, Product Type
2.5 Liver Diseases Therapeutics Drugs Market Competitive Situation and Trends
2.5.1 Liver Diseases Therapeutics Drugs Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Liver Diseases Therapeutics Drugs Players Market Share by Revenue
2.5.3 Global Liver Diseases Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Liver Diseases Therapeutics Drugs Retrospective Market Scenario by Region
3.1 Global Liver Diseases Therapeutics Drugs Retrospective Market Scenario in Sales by Region: 2017-2022
3.2 Global Liver Diseases Therapeutics Drugs Retrospective Market Scenario in Revenue by Region: 2017-2022
3.3 North America Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.3.1 North America Liver Diseases Therapeutics Drugs Sales by Country
3.3.2 North America Liver Diseases Therapeutics Drugs Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.4.1 Europe Liver Diseases Therapeutics Drugs Sales by Country
3.4.2 Europe Liver Diseases Therapeutics Drugs Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Liver Diseases Therapeutics Drugs Market Facts & Figures by Region
3.5.1 Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region
3.5.2 Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 China Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.6 Latin America Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.6.1 Latin America Liver Diseases Therapeutics Drugs Sales by Country
3.6.2 Latin America Liver Diseases Therapeutics Drugs Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Liver Diseases Therapeutics Drugs Market Facts & Figures by Country
3.7.1 Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country
3.7.2 Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Liver Diseases Therapeutics Drugs Historic Market Analysis by Type
4.1 Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2022)
4.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Type (2017-2022)
4.3 Global Liver Diseases Therapeutics Drugs Price by Type (2017-2022)
5 Global Liver Diseases Therapeutics Drugs Historic Market Analysis by Application
5.1 Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2022)
5.2 Global Liver Diseases Therapeutics Drugs Revenue Market Share by Application (2017-2022)
5.3 Global Liver Diseases Therapeutics Drugs Price by Application (2017-2022)
6 Key Companies Profiled
6.1 F. Hoffmann-La Roche
6.1.1 F. Hoffmann-La Roche Corporation Information
6.1.2 F. Hoffmann-La Roche Description and Business Overview
6.1.3 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.1.4 F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product Portfolio
6.1.5 F. Hoffmann-La Roche Recent Developments/Updates
6.2 Gilead Sciences
6.2.1 Gilead Sciences Corporation Information
6.2.2 Gilead Sciences Description and Business Overview
6.2.3 Gilead Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.2.4 Gilead Sciences Liver Diseases Therapeutics Drugs Product Portfolio
6.2.5 Gilead Sciences Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.3.4 GlaxoSmithKline Liver Diseases Therapeutics Drugs Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 Johnson & Johnson Liver Diseases Therapeutics Drugs Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 Merck
6.5.1 Merck Corporation Information
6.5.2 Merck Description and Business Overview
6.5.3 Merck Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.5.4 Merck Liver Diseases Therapeutics Drugs Product Portfolio
6.5.5 Merck Recent Developments/Updates
6.6 Achillion Pharmaceuticals
6.6.1 Achillion Pharmaceuticals Corporation Information
6.6.2 Achillion Pharmaceuticals Description and Business Overview
6.6.3 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.6.4 Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
6.6.5 Achillion Pharmaceuticals Recent Developments/Updates
6.7 AbbVie
6.6.1 AbbVie Corporation Information
6.6.2 AbbVie Description and Business Overview
6.6.3 AbbVie Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.4.4 AbbVie Liver Diseases Therapeutics Drugs Product Portfolio
6.7.5 AbbVie Recent Developments/Updates
6.8 Angion Biomedica
6.8.1 Angion Biomedica Corporation Information
6.8.2 Angion Biomedica Description and Business Overview
6.8.3 Angion Biomedica Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.8.4 Angion Biomedica Liver Diseases Therapeutics Drugs Product Portfolio
6.8.5 Angion Biomedica Recent Developments/Updates
6.9 Bayer
6.9.1 Bayer Corporation Information
6.9.2 Bayer Description and Business Overview
6.9.3 Bayer Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.9.4 Bayer Liver Diseases Therapeutics Drugs Product Portfolio
6.9.5 Bayer Recent Developments/Updates
6.10 LG Life Sciences
6.10.1 LG Life Sciences Corporation Information
6.10.2 LG Life Sciences Description and Business Overview
6.10.3 LG Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.10.4 LG Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio
6.10.5 LG Life Sciences Recent Developments/Updates
6.11 Phenex Pharmaceuticals
6.11.1 Phenex Pharmaceuticals Corporation Information
6.11.2 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Description and Business Overview
6.11.3 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.11.4 Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
6.11.5 Phenex Pharmaceuticals Recent Developments/Updates
6.12 ProMetic Life Sciences
6.12.1 ProMetic Life Sciences Corporation Information
6.12.2 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Description and Business Overview
6.12.3 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.12.4 ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product Portfolio
6.12.5 ProMetic Life Sciences Recent Developments/Updates
6.13 Raptor Pharmaceuticals
6.13.1 Raptor Pharmaceuticals Corporation Information
6.13.2 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Description and Business Overview
6.13.3 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.13.4 Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
6.13.5 Raptor Pharmaceuticals Recent Developments/Updates
6.14 Shenzhen Kangtai Biological Products
6.14.1 Shenzhen Kangtai Biological Products Corporation Information
6.14.2 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Description and Business Overview
6.14.3 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.14.4 Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product Portfolio
6.14.5 Shenzhen Kangtai Biological Products Recent Developments/Updates
6.15 Verva Pharmaceuticals
6.15.1 Verva Pharmaceuticals Corporation Information
6.15.2 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Description and Business Overview
6.15.3 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales, Revenue and Gross Margin (2017-2022)
6.15.4 Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product Portfolio
6.15.5 Verva Pharmaceuticals Recent Developments/Updates
7 Liver Diseases Therapeutics Drugs Manufacturing Cost Analysis
7.1 Liver Diseases Therapeutics Drugs Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Liver Diseases Therapeutics Drugs
7.4 Liver Diseases Therapeutics Drugs Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Liver Diseases Therapeutics Drugs Distributors List
8.3 Liver Diseases Therapeutics Drugs Customers
9 Liver Diseases Therapeutics Drugs Market Dynamics
9.1 Liver Diseases Therapeutics Drugs Industry Trends
9.2 Liver Diseases Therapeutics Drugs Market Drivers
9.3 Liver Diseases Therapeutics Drugs Market Challenges
9.4 Liver Diseases Therapeutics Drugs Market Restraints
10 Global Market Forecast
10.1 Liver Diseases Therapeutics Drugs Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Liver Diseases Therapeutics Drugs by Type (2023-2028)
10.1.2 Global Forecasted Revenue of Liver Diseases Therapeutics Drugs by Type (2023-2028)
10.2 Liver Diseases Therapeutics Drugs Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Liver Diseases Therapeutics Drugs by Application (2023-2028)
10.2.2 Global Forecasted Revenue of Liver Diseases Therapeutics Drugs by Application (2023-2028)
10.3 Liver Diseases Therapeutics Drugs Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Liver Diseases Therapeutics Drugs by Region (2023-2028)
10.3.2 Global Forecasted Revenue of Liver Diseases Therapeutics Drugs by Region (2023-2028)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Liver Diseases Therapeutics Drugs Sales Growth Rate Comparison by Type (2022-2028) & (K Pcs) & (US$ Million)
Table 2. Global Liver Diseases Therapeutics Drugs Sales Growth Rate Comparison by Application (2022-2028) & (K Pcs) & (US$ Million)
Table 3. Global Liver Diseases Therapeutics Drugs Market Size by Region (US$ Million) (2017 VS 2021 VS 2028)
Table 4. Global Liver Diseases Therapeutics Drugs Market Competitive Situation by Manufacturers in 2021
Table 5. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) of Key Manufacturers (2017-2022)
Table 6. Global Liver Diseases Therapeutics Drugs Sales Market Share by Manufacturers (2017-2022)
Table 7. Global Liver Diseases Therapeutics Drugs Revenue (US$ Million) by Manufacturers (2017-2022)
Table 8. Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers (2017-2022)
Table 9. Global Market Liver Diseases Therapeutics Drugs Average Price (USD/Pcs) of Key Manufacturers (2017-2022)
Table 10. Manufacturers Liver Diseases Therapeutics Drugs Manufacturing Sites and Area Served
Table 11. Manufacturers Liver Diseases Therapeutics Drugs Product Type
Table 12. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Liver Diseases Therapeutics Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Liver Diseases Therapeutics Drugs as of 2021)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Liver Diseases Therapeutics Drugs Sales by Region (2017-2022) & (K Pcs)
Table 16. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 17. Global Liver Diseases Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 18. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 19. North America Liver Diseases Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
Table 20. North America Liver Diseases Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 21. North America Liver Diseases Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 22. North America Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 23. Europe Liver Diseases Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
Table 24. Europe Liver Diseases Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 25. Europe Liver Diseases Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 26. Europe Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 27. Asia Pacific Liver Diseases Therapeutics Drugs Sales by Region (2017-2022) & (K Pcs)
Table 28. Asia Pacific Liver Diseases Therapeutics Drugs Sales Market Share by Region (2017-2022)
Table 29. Asia Pacific Liver Diseases Therapeutics Drugs Revenue by Region (2017-2022) & (US$ Million)
Table 30. Asia Pacific Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Table 31. Latin America Liver Diseases Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
Table 32. Latin America Liver Diseases Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 33. Latin America Liver Diseases Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 34. Latin America Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 35. Middle East and Africa Liver Diseases Therapeutics Drugs Sales by Country (2017-2022) & (K Pcs)
Table 36. Middle East and Africa Liver Diseases Therapeutics Drugs Sales Market Share by Country (2017-2022)
Table 37. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue by Country (2017-2022) & (US$ Million)
Table 38. Middle East and Africa Liver Diseases Therapeutics Drugs Revenue Market Share by Country (2017-2022)
Table 39. Global Liver Diseases Therapeutics Drugs Sales by Type (2017-2022) & (K Pcs)
Table 40. Global Liver Diseases Therapeutics Drugs Sales Market Share by Type (2017-2022)
Table 41. Global Liver Diseases Therapeutics Drugs Revenue by Type (2017-2022) & (US$ Million)
Table 42. Global Liver Diseases Therapeutics Drugs Revenue Share by Type (2017-2022)
Table 43. Global Liver Diseases Therapeutics Drugs Price by Type (2017-2022) & (USD/Pcs)
Table 44. Global Liver Diseases Therapeutics Drugs Sales (K Pcs) by Application (2017-2022)
Table 45. Global Liver Diseases Therapeutics Drugs Sales Market Share by Application (2017-2022)
Table 46. Global Liver Diseases Therapeutics Drugs Revenue by Application (2017-2022) & (US$ Million)
Table 47. Global Liver Diseases Therapeutics Drugs Revenue Share by Application (2017-2022)
Table 48. Global Liver Diseases Therapeutics Drugs Price by Application (2017-2022) & (USD/Pcs)
Table 49. F. Hoffmann-La Roche Corporation Information
Table 50. F. Hoffmann-La Roche Description and Business Overview
Table 51. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 52. F. Hoffmann-La Roche Liver Diseases Therapeutics Drugs Product
Table 53. F. Hoffmann-La Roche Recent Developments/Updates
Table 54. Gilead Sciences Corporation Information
Table 55. Gilead Sciences Description and Business Overview
Table 56. Gilead Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 57. Gilead Sciences Liver Diseases Therapeutics Drugs Product
Table 58. Gilead Sciences Recent Developments/Updates
Table 59. GlaxoSmithKline Corporation Information
Table 60. GlaxoSmithKline Description and Business Overview
Table 61. GlaxoSmithKline Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 62. GlaxoSmithKline Liver Diseases Therapeutics Drugs Product
Table 63. GlaxoSmithKline Recent Developments/Updates
Table 64. Johnson & Johnson Corporation Information
Table 65. Johnson & Johnson Description and Business Overview
Table 66. Johnson & Johnson Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 67. Johnson & Johnson Liver Diseases Therapeutics Drugs Product
Table 68. Johnson & Johnson Recent Developments/Updates
Table 69. Merck Corporation Information
Table 70. Merck Description and Business Overview
Table 71. Merck Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 72. Merck Liver Diseases Therapeutics Drugs Product
Table 73. Merck Recent Developments/Updates
Table 74. Achillion Pharmaceuticals Corporation Information
Table 75. Achillion Pharmaceuticals Description and Business Overview
Table 76. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 77. Achillion Pharmaceuticals Liver Diseases Therapeutics Drugs Product
Table 78. Achillion Pharmaceuticals Recent Developments/Updates
Table 79. AbbVie Corporation Information
Table 80. AbbVie Description and Business Overview
Table 81. AbbVie Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 82. AbbVie Liver Diseases Therapeutics Drugs Product
Table 83. AbbVie Recent Developments/Updates
Table 84. Angion Biomedica Corporation Information
Table 85. Angion Biomedica Description and Business Overview
Table 86. Angion Biomedica Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 87. Angion Biomedica Liver Diseases Therapeutics Drugs Product
Table 88. Angion Biomedica Recent Developments/Updates
Table 89. Bayer Corporation Information
Table 90. Bayer Description and Business Overview
Table 91. Bayer Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 92. Bayer Liver Diseases Therapeutics Drugs Product
Table 93. Bayer Recent Developments/Updates
Table 94. LG Life Sciences Corporation Information
Table 95. LG Life Sciences Description and Business Overview
Table 96. LG Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 97. LG Life Sciences Liver Diseases Therapeutics Drugs Product
Table 98. LG Life Sciences Recent Developments/Updates
Table 99. Phenex Pharmaceuticals Corporation Information
Table 100. Phenex Pharmaceuticals Description and Business Overview
Table 101. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 102. Phenex Pharmaceuticals Liver Diseases Therapeutics Drugs Product
Table 103. Phenex Pharmaceuticals Recent Developments/Updates
Table 104. ProMetic Life Sciences Corporation Information
Table 105. ProMetic Life Sciences Description and Business Overview
Table 106. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 107. ProMetic Life Sciences Liver Diseases Therapeutics Drugs Product
Table 108. ProMetic Life Sciences Recent Developments/Updates
Table 109. Raptor Pharmaceuticals Corporation Information
Table 110. Raptor Pharmaceuticals Description and Business Overview
Table 111. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 112. Raptor Pharmaceuticals Liver Diseases Therapeutics Drugs Product
Table 113. Raptor Pharmaceuticals Recent Developments/Updates
Table 114. Shenzhen Kangtai Biological Products Corporation Information
Table 115. Shenzhen Kangtai Biological Products Description and Business Overview
Table 116. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 117. Shenzhen Kangtai Biological Products Liver Diseases Therapeutics Drugs Product
Table 118. Shenzhen Kangtai Biological Products Recent Developments/Updates
Table 119. Verva Pharmaceuticals Corporation Information
Table 120. Verva Pharmaceuticals Description and Business Overview
Table 121. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Sales (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2017-2022)
Table 122. Verva Pharmaceuticals Liver Diseases Therapeutics Drugs Product
Table 123. Verva Pharmaceuticals Recent Developments/Updates
Table 124. Production Base and Market Concentration Rate of Raw Material
Table 125. Key Suppliers of Raw Materials
Table 126. Liver Diseases Therapeutics Drugs Distributors List
Table 127. Liver Diseases Therapeutics Drugs Customers List
Table 128. Liver Diseases Therapeutics Drugs Market Trends
Table 129. Liver Diseases Therapeutics Drugs Market Drivers
Table 130. Liver Diseases Therapeutics Drugs Market Challenges
Table 131. Liver Diseases Therapeutics Drugs Market Restraints
Table 132. Global Liver Diseases Therapeutics Drugs Sales Forecast by Type (2023-2028) & (K Pcs)
Table 133. Global Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Type (2023-2028)
Table 134. Global Liver Diseases Therapeutics Drugs Revenue Forecast by Type (2023-2028) & (US$ Million)
Table 135. Global Liver Diseases Therapeutics Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 136. Global Liver Diseases Therapeutics Drugs Sales Forecast by Application (2023-2028) & (K Pcs)
Table 137. Global Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Application (2023-2028)
Table 138. Global Liver Diseases Therapeutics Drugs Revenue Forecast by Application (2023-2028) & (US$ Million)
Table 139. Global Liver Diseases Therapeutics Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 140. Global Liver Diseases Therapeutics Drugs Sales Forecast by Region (2023-2028) & (K Pcs)
Table 141. Global Liver Diseases Therapeutics Drugs Sales Market Share Forecast by Region (2023-2028)
Table 142. Global Liver Diseases Therapeutics Drugs Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 143. Global Liver Diseases Therapeutics Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Liver Diseases Therapeutics Drugs
Figure 2. Global Liver Diseases Therapeutics Drugs Market Share by Type in 2021 & 2028
Figure 3. Oral Liver Diseases Therapeutics Drugs Product Picture
Figure 4. Injection Liver Diseases Therapeutics Drugs Product Picture
Figure 5. Global Liver Diseases Therapeutics Drugs Market Share by Application in 2021 & 2028
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Other
Figure 9. Global Liver Diseases Therapeutics Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 10. Global Liver Diseases Therapeutics Drugs Market Size (2017-2028) & (US$ Million)
Figure 11. Global Liver Diseases Therapeutics Drugs Sales (2017-2028) & (K Pcs)
Figure 12. Liver Diseases Therapeutics Drugs Sales Share by Manufacturers in 2021
Figure 13. Global Liver Diseases Therapeutics Drugs Revenue Share by Manufacturers in 2021
Figure 14. The Global 5 and 10 Largest Liver Diseases Therapeutics Drugs Players: Market Share by Revenue in 2021
Figure 15. Liver Diseases Therapeutics Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2017 VS 2021
Figure 16. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region (2017-2022)
Figure 17. Global Liver Diseases Therapeutics Drugs Sales Market Share by Region in 2021
Figure 18. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region (2017-2022)
Figure 19. Global Liver Diseases Therapeutics Drugs Revenue Market Share by Region in 2021
Figure 20. U.S. Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 21. Canada Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 22. Germany Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 23. France Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 24. U.K. Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 25. Italy Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 26. Russia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 27. China Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 28. Japan Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 29. South Korea Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 30. India Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 31. Australia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 32. China Taiwan Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 33. Indonesia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 34. Thailand Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 35. Malaysia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 36. Mexico Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 37. Brazil Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 38. Argentina Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 39. Turkey Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 40. Saudi Arabia Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 41. UAE Liver Diseases Therapeutics Drugs Revenue Growth Rate (2017-2022) & (US$ Million)
Figure 42. Sales Market Share of Liver Diseases Therapeutics Drugs by Type (2017-2022)
Figure 43. Manufacturing Cost Structure of Liver Diseases Therapeutics Drugs
Figure 44. Manufacturing Process Analysis of Liver Diseases Therapeutics Drugs
Figure 45. Liver Diseases Therapeutics Drugs Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
F. Hoffmann-La Roche Gilead Sciences GlaxoSmithKline Johnson & Johnson Merck Achillion Pharmaceuticals AbbVie Angion Biomedica Bayer LG Life Sciences Phenex Pharmaceuticals ProMetic Life Sciences Raptor Pharmaceuticals Shenzhen Kangtai Biological Products Verva Pharmaceuticals